Immunonutrition for Diabetic Foot Ulcers
Effects of Supplemental Immunonutrition on Healing of Chronic Non-Healing Lower Extremity Ulcers in Diabetic Patients: A Pilot Study
Sponsor: Prisma Health-Midlands
Terminated
Not enough patients meeting eligibility criteria to complete the study. It took months from study initiation to enroll 1 participant in February 2023. Once it was clear it was not possible to enroll another participant, the study was terminated.
Other terminated trials from Prisma Health-Midlands
Other Diabetes Mellitus trials with similar outcome
Listed as NCT05281562, this PHASE2/PHASE3 trial focuses on Diabetes Mellitus and Diabetic Foot Ulcer and remains terminated or withdrawn. Sponsored by Prisma Health-Midlands, it has been updated 8 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Jan 2025 — Present [monthly]
Terminated PHASE2/PHASE3
-
Sep 2024 — Jan 2025 [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Apr 2023 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
Status: Enrolling By Invitation → Terminated
-
Feb 2023 — Apr 2023 [monthly]
Enrolling By Invitation PHASE2_PHASE3
▶ Show 3 earlier versions
-
Jan 2023 — Feb 2023 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Oct 2022 — Jan 2023 [monthly]
Enrolling By Invitation PHASE2_PHASE3
Status: Not Yet Recruiting → Enrolling By Invitation
-
Apr 2022 — Oct 2022 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Prisma Health-Midlands
For direct contact, visit the study record on ClinicalTrials.gov .